Esperion Therapeutics logo
Esperion Therapeutics ESPR
$ 2.47 2.49%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Esperion Therapeutics Long Term Debt Current 2011-2024 | ESPR

Annual Long Term Debt Current Esperion Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.55 M 384 K 1.39 M 2.59 M 454 K - 1.04 M 1.71 M 1.6 M 638 K - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2.59 M 384 K 1.26 M